chemogenomics

Adopted chemogenomics usage

Record whose definition is used and whether it centres on target-space profiling, genomic perturbation responses or their integration.

1. What explicit definition makes this investigation an instance of chemogenomics? definition
2. Which source or research community supplies that definition? provenance

Chemical-biological inference unit

Specify whether the intended conclusion concerns a compound-target pair, target-family profile or genotype-dependent perturbation response.

1. What relationship is the investigation designed to establish, and at what biological resolution? definition
2. Which adjacent questions about chemical genetics, pharmacogenomics or drug optimisation are outside this investigation? boundary

Compound selection and integrity

Record the collection's selection rationale, chemical diversity and sample-level identity or quality limitations.

1. Were compounds selected for scaffold diversity, known target coverage, probe quality or another explicit objective? provenance
2. What identity, purity, solubility and stability evidence supports interpreting the tested samples as the intended perturbations? measurement

Tested biological universe

Record target identities, constructs and genomic backgrounds against an explicitly bounded intended universe.

1. Which targets, isoforms, species and genomic backgrounds were included, and why? provenance
2. What fraction of the intended compound-target or compound-background combinations was tested, and which regions remain unobserved? measurement

Endpoint and exposure context

Record the measured phenomenon, concentration dependence, exposure duration and experimental context.

1. Does the endpoint measure binding, biochemical function, cellular engagement, phenotype or genomic response? definition
2. What doses, exposure times, replicates and response limits support the reported activity or inactivity? measurement

Comparison eligibility

Record controls and transformations that justify comparing observations while retaining censored, conflicting and missing results.

1. What controls address aggregation, reporter interference, general cytotoxicity or other plausible non-target explanations? measurement
2. Which observations can be compared directly, and which require stratification because endpoints or conditions differ? boundary
3. How are original records, identifier mappings and normalisation steps traceable to the resulting activity profile? provenance

Association to causal explanation

Record support and competing explanations for assigning a target or pathway to a chemical perturbation.

1. Which target assignments come from direct experiments, profile similarity, genetic interactions or computational prediction? provenance
2. What engagement, resistance, rescue or orthogonal perturbation evidence would distinguish the proposed mechanism from alternatives? action

Bounded selectivity and genotype effects

Record selectivity within the tested panel and separate genomic associations from explanations involving exposure, expression or other context.

1. Against which tested targets and at which concentrations is the compound considered selective or multi-target active? measurement
2. What evidence separates a genotype-dependent response from differences in target expression, uptake, metabolism or general sensitivity? boundary

Generalisation and leakage

For computational components, record whether evaluation tests new pairs, new chemical scaffolds, new targets or new biological contexts.

1. Does evaluation hold out related scaffolds, homologous targets or shared experimental sources when required by the intended use? measurement
2. How are untested pairs distinguished from measured negatives, and how does that choice affect reported performance? measurement
3. For which chemical and biological regions is predictive reliability still unevaluated? boundary

Discriminating validation plan

Record the next test most likely to resolve a consequential uncertainty and the outcomes that would change the conclusion.

1. Which next compound, target, genomic background or orthogonal assay would best distinguish the leading explanations? action
2. What result would justify accepting, narrowing or rejecting the proposed association, and what uncertainty would remain? action

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these check these first hold for the sense of chemogenomics this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these kinds and varieties hold for the sense of chemogenomics this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these identifiers and schemes hold for the sense of chemogenomics this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these real-world use hold for the sense of chemogenomics this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these typical measurements hold for the sense of chemogenomics this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these failure modes and hazards hold for the sense of chemogenomics this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these neighbouring kinds and how to tell them apart hold for the sense of chemogenomics this model covers, and on what evidence? provenance